维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Schuler JC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Current and emerging concepts in non-invasive and minimally invasive management of spine metastasis显示文摘	Bhatt AD Schuler JC Boakye M	2013	Cancer Treat Rev2013，39，2：	1
2	Symptom control and quality of life in LUX-Lung 3 : a phase m study of afatinib or cisplatin/ pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations显示文摘	Yang JC Hirsh V Schuler M	2013	J Clin Oncol2013，31，27：	1
3	Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6 ) : analysis of overall survival data from two randomised, phase 3 trials显示文摘	Yang JC lVu YL Schuler M	2015	Lancet Oncol2015，16，2：	1
4	p53 trig-gers apoptosis in oncogen-expressing fibroblasts by the induction of Noxa and mitoChondrial Bax translocation显示文摘	Maurer U Goldstein JC	2003	Cell Death Differ2003，10，4：	1
5	p53 induces apoptosis by caspase activation through mitochondrial cytochrome crelease显示文摘	Schuler M Bossy-Wetzel E Goldstein JC	2000	J Biol Chem2000，275，10：	1
6	Current and emerging concepts in non-invasive and minimally invasive management of spine metastasis显示文摘	Bhatt AD Schuler JC Boakye M	2013	Cancer Treat Rev2013，39，：	1
7	Afatinib versus cis- platin-based chemotherapy for EGFR mutation-positive lung adenoearcinoma(LUX-Lung 3 and LUX-Lung 6): anal-ysis of overall survival data from two randomised,phase 3 trials 显示文摘	Yang JC Wu YL Schuler M	2015	Lancet 0ncol2015，16，2：	1
8	Afatinib beyondprogression in patients with non-small-cell lung cancerfollowing chemotherapy, erlotinib/gefitinib and afatinib :phase HI randomized LUX-Lung 5 trial显示文摘	Schuler M Yang JC Park K	2016	Ann Oncol2016，27，3：	1
9	p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial BaX translocation显示文摘	Schuler M Maurer U Goldstein JC	2003	Cell Death Differ2003，10，4：	1
10	Afatinib versus cisplatin-based chemotherapy for EGFR mutation- positive lung adenocarcinoma (LUX - Lung 3 and LUX - Lung 6 ) : analysis of overall survival data from two randomised, phase 3 trials显示文摘	YANG JC WU YL SCHULER M	2015	Lancet Oncol2015，16，2：	1
11	Current and emerging concepts in non-invasive and minimally invasive management of spine metastasis显示文摘	Bhatt AD Schuler JC Boakye M	2013	Cancer Treat Rev2013，39，2：	1
12	Afatinib beyond progression in patients with non small cell lung cancer following chemotherapy,erlotinib/gefitinib and afatinib:phaseⅡI randomized LUX-Lung 5 trial显示文摘	Schuler M Yang JC Park K	2015	Ann Oncol2015，，：	1
13	Symptom control and quality oflife in LUX-Lung 3 : A phase IE study of afatinib or cisplatin/peme-trexed in patients with advanced lung adenocarcinoma with EGFR mu-tations显示文摘	Yang JC Hirsh V Schuler M	2013	J Clin Oncol2013，31，27：	1
14	Symptom controland quality of life in LUX-Lung 3 : a phase HI study ofafatinib or cisplatin/pemetrexed in patients with advancedlung adenocarcinoma with EGFR mutations 显示文摘	Yang JC Hirsh V Schuler M	2013	J ClinOncol2013，31，27：	1
15	P53 triggers apoptosis in oncogene - expressing fibrob lasts by the induction of noxa and mi tochondrial bax translocation显示文摘	Schuler M Maurer U Goldstein JC	2003	Cell Death Differ2003，1，：	1
16	p53 triggers apoptosis fibroblasts by the induction of Noxa and mi- tochondrial Bax translocation 显示文摘	Schuler M MaurerU in Goldstein JC	2003	Cell Death Differ2003，10，4：	1
17	Afatinib versuscisplatin-based chemotherapy for EGFR mutation-posi-tive lung adenocarcinoma ( LUX-Lung 3 and LUX-Lung6) : analysis of overall survival data from two random-ised, phase 3 trials显示文摘	Yang JC Wu YL Schuler M	2015	Lancet Oncol2015，16，2：	1
18	Matinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma ( LUX-Lung 3 and LUX-Lung 6 ) : analysis of overall survival data from two randomised, phase 3 trials 显示文摘	Yang JC Wu YL Schuler M	2015	Lancet Oncol2015，16，2：	1
19	Current and emerging concepts in non-invasive and minimally invasive management of spine metastasis显示文摘	Bhatt AD Schuler JC Boakye M	2013	Cancer Treat Rev2013，39，2：	1
20	P53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation 显示文摘	Schuler M Maurer U Goldstein JC	2003	Cell Death Differ2003，10，45：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示